Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| SMALLMNK | SMALLPOX + MONKEYPOX (JYNNEOS) | BAVARIAN NORDIC | 2 | FDP00017 | IM / LA |
The treatment was the second of a two-series vaccination; the outcome was uneventful, with no symptoms or signs of reaction reported.
None reported
Coccidioidomycosis Symptomatic HIV infection Preventative health care Lung mass History of tobacco use Essential hypertension Adenomatous polyp of colon COVID-19 History of hepatitis C PTSD (post-traumatic stress disorder) Hyperlipidemia High grade squamous intraepithelial lesion (HGSIL) on Papanicolaou smear Vegan diet History of hyperlipidemia History of substance use disorder History of hypertension
fish oil/borage/flax/om3,6,9 1 (OMEGA 3-6-9 ORAL) multivitamin tab calcium carbonate (OS-CAL) 500 mg calcium (1,250 mg) tablet TURMERIC ORAL Lactobac no.41/Bifidobact no.7 (PROBIOTIC-10 ORAL) bictegrav-emtricit-tenofov (BIKTARVY) 50-200-25
Bactrim [Sulfamethoxazole-trimethoprim]Rash, PenicillinsHives Compazine [Prochlorperazine] Sulfa (Sulfonamide Antibiotics)
N/A